Applied Nutrition Targets Growing Market of Weight-Loss Drug Users with New Product Range
The health and wellness brand Applied Nutrition is significantly broadening its product offerings to specifically cater to customers using weight-loss medications, following a substantial surge in demand over the past year. The London-listed company has identified a major business opportunity arising from the sharp increase in Britons utilising GLP-1 treatments, such as Mounjaro and Wegovy.
Strategic Expansion into GLP-1 Friendly Products
Applied Nutrition, which already provides GLP-1-compatible high-protein ready meals introduced in late 2025, has confirmed that additional products designed for this expanding market will be launched later this year. Thomas Ryder, founder and chief executive of the Liverpool-based firm, emphasised the strategic importance of this move.
"The GLP-1 user is a growing customer. We see this as a consumer at the start of their weight loss journey who is now looking at how the medication can help them," Ryder stated. "There is an opportunity, as those customers often need supplements and require smaller portions. I believe this is a catalyst for the health and wellness space if we keep that consumer in mind."
Ryder added, "We have a number of products we will bring to market in this area because we do see that sector growing."
Rising Demand and Market Context
Research from University College London indicates that at least 1.6 million Britons have used weight-loss jabs in the past year, highlighting the scale of this consumer base. Applied Nutrition's expansion aligns with this trend, aiming to meet the specific nutritional needs of individuals on these medications.
The company has reported strong financial performance, driven by targeting new customer opportunities and diversifying its sales channels, including expansion into UK retail stores. In March, Applied Nutrition announced robust results, with pre-tax profits soaring by 77.1% to £20.9 million for the six months ending 31 January, compared to the previous year.
Sales also experienced a significant uplift, rising by 56.5% to £74.5 million over the same half-year period. However, the firm cautioned that sales volumes in the Middle East are anticipated to be impacted by the ongoing conflict in the region.
Future Outlook and Operational Resilience
Despite regional challenges, Applied Nutrition stated it still expects to meet revenue targets for the year of approximately £140 million. The company highlighted its operational agility in managing disruptions, noting, "Importantly, we have managed similar disruption in the past, supported by the flexibility of our operations."
"In this instance, we are working closely with customers to adapt our routes into the region and logistics arrangements to safeguard continued supply to those customers," the firm added, underscoring its commitment to maintaining service amidst external pressures.
